The Evolving Treatment Paradigm for Platinum-Resistant Ovarian Cancer

Floortje J Backes, MD, discusses current treatment considerations for platinum-resistant ovarian cancer.

Floortje J Backes, MD, discusses how mirvetuximab soravtansine has affected the management of platinum-resistant ovarian cancer.

Floortje J. Backes, MD, discusses how to approach FRα testing in ovarian cancer.

Floortje J. Backes, MD, discusses data for mirvetuximab soravtansine in FRα-positive, platinum-sensitive ovarian cancer

Floortje J. Backes, MD, discusses other potential roles for mirvetuximab soravtansine and other antibody-drug conjugates in ovarian cancer.

Floortje J. Backes, MD, discusses ongoing research to watch in ovarian cancer.